Nicole Lemerond
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Nicole Lemerond is currently an Independent Director at InMed Pharmaceuticals, Inc. since 2022, MediciNova, Inc. since 2023, and GeoVax Labs, Inc. since 2022.
Formerly, Ms. Lemerond was Managing Partner at NV Capital Management from 2010 to 2022.
Ms. Lemerond completed undergraduate education at Cornell University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MEDICINOVA, INC. -.--% | 24.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
GEOVAX LABS, INC. -.--% | 17.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| 19.12.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 08.08.2022 |
| GEOVAX LABS, INC. | Direktor/Vorstandsmitglied | 31.08.2022 |
| MEDICINOVA, INC. | Direktor/Vorstandsmitglied | 04.08.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
NV Capital Management | Corporate Officer/Principal | 01.08.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
MediciNova, Inc.
MediciNova, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which develops novel therapeutics for the treatment of neurological and other disorders | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeoVax Labs, Inc.
GeoVax Labs, Inc. BiotechnologyHealth Technology Develops vaccines for diseases caused by Human Immunodeficiency Virus and other infectious agents | Health Technology |
NV Capital Management |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen